• Article Title：Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours. Author：Qin Wang • Journal Title：Nature Nanotechnology • Impact Factor：38.3

XENOPIA INVESTMENT LTD, a standout distributor for NEST Biotechnology, has successfully obtained the Medical Device Registration Certificate for NEST’s laboratory supplies for cell cultivation in the country of Kenya.

It is incredible how time flies. It seems like just yesterday when the NEST brand was created, and now, 15 years have already elapsed.

World Diabetes Day is a global awareness campaign held on November 14th each year to raise awareness about diabetes, its prevention, and its management.

After a year-long litigation battle, NEST Biotechnology Co.,Ltd, has emerged victoriously in a patent infringement case filed by Copan Italia S.p.A. and Copan Industries, Inc. (“Copan”). The complaint alleged that NEST and some other swab manufactures and sellers violated section 337 of the Tariff Act of 1930 in the importation into the United States and sale of certain flocked swabs, kits containing flocked swabs, and methods of using same that infringe patents asserted. Copan requested that the USITC issue a general exclusion order, or in the alternative a limited exclusion order, and cease and desist orders.